Check out the companies making headlines before the bell. ImmunityBio — The biotech company soared 13%, adding to a 30% gain in the previous session driven by strong guidance for bladder cancer drug Anktiva. ImmunityBio expects full-year revenue for the drug to increase 700%. Worthington Steel — The Columbus, Ohio-based maker of hot and cold rolled steel rose 7% after it agreed to buy German metal fabricator Klöckner Corp. for an enterprise value of $2.4 billion. Coupang — Shares rose about 3% after Deutsche Bank upgraded the South Korean retail giant to a takeover target, saying most regulatory uncertainties had been factored in. QXO — Shares fell 7% after the roofing material maker announced it would sell $750 million in common stock. PNC — The Pittsburgh-based bank rose 4% after reporting better-than-expected fourth-quarter results and providing encouraging guidance. PNC reported revenue of $5.96 billion, compared to LSEG’s consensus estimate of $5.89 billion. Earnings per share came to $4.88, beating expectations of $4.22 per share. PNC also expects total sales growth to be about 11% through the end of 2026, higher than analysts’ expectations of 8.7%. Honeywell — This industrial giant rose nearly 2% after receiving an upgrade from neutral to overweight at JPMorgan. The bank said investors should buy shares as Honeywell moves forward with its planned separation. Energy stocks — Stocks rose after the Trump administration pushed through emergency bids to encourage technology companies to finance power plants as energy-hungry data centers proliferate. GE Vernova and Bloom Energy rose 3%, while Okro rose more than 1%. — CNBC’s Fred Imbert contributed reporting
